Interestingly, the mRNA translation is dysregulated in many cancers, this raises the potential of utilizing the mRNA capping enzymes as therapeutic targets to selectively inhibit protein synthesis in cancer cells12, where RNMT playing a major role. Here, RNMT is linked to cancer.